2024.05.14
Combination Assay of Methylated HOXA1 with Tumor Markers Shows High Sensitivity for Detection of Early-Stage Hepatocellular Carcinoma
An article on the research results of a research group led by Dr. Hiroaki Nagano (Gastroenterological, Breast and Endocrine Surgery) and Dr. Taro Takami (Gastroenterology and Hepatology) of Division of Advanced Cell Therapy, was posted on the University’s website.
Please click the following link for details.
肝細胞がんに対するリキッドバイオプシー検査と腫瘍マーカーを組み合わせた新規診断インデックスの開発｜国立大学法人山口大学HP